08:09:50 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for July 18, 2017

2017-07-18 20:57 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange gained 1.39 points to 763.71 Tuesday. Cameron Chell and Erika Racicot's NEX shell, Pounce Technologies Inc. (POI), resumed trading today. It fell eight cents to 12 cents on 128,585 shares. The shell has been halted since January, when it was still called Slyce Inc.

Slyce was an image recognition software company, founded in 2012 by Mr. Chell. In July, 2014, Mr. Chell took Slyce public through Darren Devine's NEX shell, Oculus Ventures Corp. Mr. Devine's Oculus did not sell a private placement in connection with this going-public deal, but the target did: Slyce sold 20 million shares at 60 cents. In its first few months as a public company, Slyce was a busy trader, peaking at $1.19 in November, 2014. The 201 subscribers to its 60-cent private placement had eight months to get out of their investment with a profit, before the stock fell below their break-even price. Among the subscribers were: Ian Clark's Salida Strategic Growth Fund SARL, which bought 1,980,067 shares; Steve Palmer's AlphaNorth Asset Management, which bought 417,000; Mike Veldhuis's Blackstone Capital Partners Inc., with 340,000; Andrew DeFrancesco's Delavaco Holdings Inc., with 190,000; former broker Luke Norman, who bought 40,000; Nick DeMare's DNG Capital Corp., which bought 40,000; and Varshney Capital Corp., which bought 25,000 shares.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed